DGX Quest Diagnostics
Permanent stock page ↗Health Care · S&P 500
Next earnings: not announced yet
What 16 analyst firms say about Quest Diagnostics: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
13 rated views · 16 analyst/firm records · 16 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8023
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8058
Recent analyst activity · last 90 days
Our tracked history has 10 reports on DGX from 8 analyst firms in the last 90 days (16 firms in the past year).
Comparing each firm's latest target with its previous one: 7 raised their price target.
No firm's latest available rating differs from its previous one.
Latest observed target change: Evercore raised its target from $225.00 (set 21 Apr 2026) to $240.00 on 28 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | David A Toung | ConflictConflicting reports · excluded | 29 Jul 2026 | 260.00 USD |
| Baird | Eric Coldwell | ConflictConflicting reports · excluded | 23 Oct 2026 | 262.00 USD |
| Barclays | Luke Sergott | Buy | 7 Oct 2026 | 260.00 USD |
| Citigroup | Patrick Donnelly | Hold | 10 Feb 2026 | 215.00 USD |
| Evercore ISI | Elizabeth Anderson | Hold | 28 Oct 2026 | 240.00 USD |
| Jefferies | Tycho W Peterson | Buy | 23 Oct 2026 | 275.00 USD |
| JPMorgan | Lisa Gill | Hold | 28 Jul 2026 | 250.00 USD |
| Leerink Partners | Michael Cherny | Buy | 23 Jul 2026 | 265.00 USD |
| Mizuho | Ann Hynes | Buy | 24 Jul 2026 | 260.00 USD |
| Piper Sandler | David M Westenberg | Hold | 29 Jul 2026 | — |
| Redburn | Jamie Clark | Buy | 27 Oct 2026 | 279.00 USD |
| Truist | David MacDonald | Hold | 21 Sep 2026 | 260.00 USD |
| UBS | Kevin Caliendo | Hold | 19 Oct 2026 | 250.00 USD |
| Weiss Ratings | Unnamed analyst | — | 21 Oct 2026 | — |
| William Blair | Jared Haase | Buy | 23 Jul 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 10 Feb 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.